.After F2G's initial attempt to receive a new course of antifungal to market was derailed due to the...
.Moderna has sworn to cut R&D costs by $1.1 billion by 2027. The selection to retract the spendin...
.Merely four months after Sanofi wager $80 million in beforehand cash on Pivot Therapies' losmapimod...
.Cancer company Oncternal Therapeutics is actually folding all its medical tests and giving up perso...
.Roche is actually keeping out chances that its own injectable weight problems prospect can eventual...
.Novo Nordisk has elevated the cover on a period 1 trial of its dental amylin and GLP-1 receptor co-...
.Just a couple of short full weeks after winning an FDA Fast Track tag for its own investigational B...
.Soon after a good information decrease for Eli Lilly's efsitora alfa, the Indianapolis-based compan...
.BridgeBio Pharma is lowering its gene treatment spending plan and also drawing back from the modali...
.GSK's effort to create the initial vaccination for genital herpes simplex infection (HSV) has finis...